Development of a new methodology for dissolving tablets containing diltiazem hydrochloride marketed in Brazil using design of experiment
DOI:
https://doi.org/10.1590/s2175-97902026e24838Keywords:
Diltiazem hydrochloride, Tablets, Dissolution test, Factorial design of experiments, Quality controlAbstract
Diltiazem hydrochloride (DH) is a calcium channel blocker used to modify or restore normal heartrhythm in cardiovascular diseases. The aim of this study was to develop and validate a new innovativemethod using UV molecular absorption spectrophotometry to evaluate the in vitro dissolution of DH using a factorial design of experiments. Physical and physicochemical tests were performed. The dissolution profiles of DH tablets (30 and 60 mg) available as the reference, generic and similardrugs were compared. The dissolution test was used to obtain and compare dissolution profiles and todetermine the similarity of pharmaceutical formulations (USP type 2 apparatus at 75 rpm, with 750 mLof water at 37.0 ± 0.5 oC for 120 minutes). Only samples G30 and G60 showed compliance with theparameters established by the Brazilian Pharmacopoeia in all tests. Drug dissolution percentages are inaccordance with the Brazilian and American Pharmacopoeias (>75% dissolution in 180 minutes). Using the proposed new method, it was observed that > 80% of DH was released in approximately 60 minutes. The proposed method was found to be sensitive, rapid and efficient for the quality control of DH tablets.
Downloads
References
Alkhalidi BA, Alkhatib HS, Khdair AA. Comparative Dissolution of Diltiazem Immediate and Extended Release Products Using Conventional USP and Innovative Dissolution Paddles. The Open Drug Deliv J. 2010;4(2):48-54. DOI: 10.2174/1874126601004020048.
Amidon GL, Lennerñas H, Shah VP, Crison JR. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability. Pharm Res. 1995;12(3):413-420. DOI:10.1023/a:1016212804288.
Anand O, Yu LX, Conner DP, Davit BM. Dissolution testing for generic drugs: An FDA Perspective. AAPS J. 2011;13(3):328. DOI: 10.1208/s12248-011-9272-y.
Arafat M, Sarfraz M, Bostanudin MF, Esmaeil A, Salam A, AbuRuz S. In vitro and in vivo evaluation of oral controlled release formulation of bcs class i drug using polymer matrix system. Pharmaceuticals. 2021;14(9):929. DOI: 10.3390/ph14090929.
Bezerra MP, Rodrigues LNC. Quality by Design (QbD) as a tool for optimization of pharmaceutical processes. Infarma. 2017;29(1):5-12. DOI: 10.14450/2318-9312.
Bhakta HC, Lin JM, Grover WH. Measuring dissolution profiles of single controlled-release drug pellets. Sci Rep. 2020;10(19734): DOI: 10.1038/s41598-020-76089-z.
Brasil. ANVISA. National Health Surveillance Agency. Brazilian Pharmacopoeia 7ª edition. Volume 2 - Monographs. Brasília: National Health Surveillance Agency. 2024a.
Brasil. ANVISA. National Health Surveillance Agency. Concepts and definitions. 2024b. Available at: https://www.gov.br/anvisa/pt-br/acessoainformacao/ perguntasfrequentes/medicamentos/conceitos-edefinicoes (accessed jun 02, 2024).
Brasil. ANVISA. National Health Surveillance Agency. Brazilian Pharmacopoeia 7ª edition. Volume 1. Brasília: National Health Surveillance Agency. 2024c.
Brasil. ANVISA. National Health Surveillance Agency. Notificação de Descontinuação e Reativação de Fabricação e Importação de Medicamentos. 2021. Available from: https://sad.anvisa.gov.br/MicroStrategy/ servlet/mstrWeb (accessed feb 11, 2023).
Brasil. ANVISA. National Health Surveillance Agency. Resolução RDC n° 166, de 24 de Julho de 2017. Dispõe sobre a validação de métodos analíticos e dá outras providências. Available from: https://www20.anvisa. gov.br/coifa/pdf/rdc166.pdf (accessed jan 10, 2022).
Brasil. Ministry of Health. National Health Surveillance Agency. Resolution RDC n° 749 de 5 de setembro de 2022. Dispõe sobre isenção de estudos de bioequivalência/biodisponibilidade relativa. Diário Oficial da União. 2022;171(1):67.
Brasil. ANVISA. National Health Surveillance Agency. Resolution Nº 31, Dispõe sobre a realização dos Estudos de Equivalência Farmacêutica e de Perfil de Dissolução Comparativo. 2010. Available from: https://portal.anvisa.gov.br/documents/10181/2718376/ RDC_31_2010_COMP.pdf/85adb5d2-94f7-4b318b59-754ecd1ccd52 (accessed Feb 26, 2022).
Costa AS, Silva DDM, Jesus LC, Luiz LC, Batista RT, Bell MJV, Anjos VC. The importance of the choice of excipients in drug manipulation. Braz J Hea Rev 2021;4(4):16659-70. DOI:10.34119/bjhrv4n4-180
Deidda R, Avohou HT, Baronti R, Davolio P, Pasquini B, Del Bubba M, Hubert C, Hubert P, Orlandini S, Furlanetto S. Analytical quality by design: development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extracts. J Pharm Biomed Anal. 2019;166:326-335. DOI: 10.1016/j.jpba.2019.01.032
Ferreira MS, Teles Júnior GAC, Carvalho Júnior CMR, Dias FS, Santos Júnior WSD, Souza MOG, Santos Júnior AF. Evaluation of physicochemical properties and dissolution studies on quality control of low water solubility drugs (raw materials and pharmaceutical formulations). Rev Colomb Cienc Quim Farm. 2020;49(2):329-354. DOI: 10.15446/rcciquifa. v49n2.89486.
Ghourichay M, Kiaie S, Nokhodchi A, Javadzadeh Y. Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives. Biomed Res Int. 2021;6618934. DOI: 10.1155/2021/6618934.
Grangeia HB, Silva C, Simões SP, Reis MS. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. Eur J Pharm Biopharm. 2020;147:19-37. DOI: 10.1016/j.ejpb.2019.12.007.
Infinity Pharma. Guia de Formulações: Excipientes. 2020. Available from: https://infinitypharma. com.br/wp-content/uploads/2020/04/GUIA-DEFORMULA%C3%87%C3%95ES-2020-Excipientes. pdf (accessed on: feb 11, 2022).
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Pharmaceutical Development, Q8(R2), Current Step 5 version, August 2009. Available from: https://www. ema.europa.eu/en/documents/scientific-guideline/ international-conference-harmonisation-technicalrequirements-registration-pharmaceuticals-humanuse_en-11.pdf (accessed jun 02, 2024).
International Conference on Harmonization (ICH). International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use. ICH Q14: Analytical Procedure Development and Revision of Q2(R10). Analytical Validation: ICH Harmonized Tripartite Guideline: Geneva, Switzerland, 2018. Available from: https://database.ich.org/sites/default/ files/Q2R2-Q14_EWG_Concept_Paper.pdf (accessed jan 10, 2022).
Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 2004;1(1):85-96. DOI: 10.1021/mp034006h.
Kovács B, Péterfi O, Kovács-Deák B, Székely-Szentmiklósi I, Fülöp I, Bába LI, Boda F. Quality-bydesign in pharmaceutical development: From current perspectives to practical applications. Acta Pharm. 2021;71(4):497-526. DOI: 10.2478/acph-2021-0039
Malachias MV, Souza WK, Plavnik FL, Rodrigues CI, Brandão AA, Neves MF, et al. Brazilian Society of Cardiology. 7th Brazilian Guideline for Arterial Hypertension. Arq Bras Cardiol. 2016;107(3):21.
Manzoor MF, Riaz S, Verma DK, Waseem M, Goksen G, Ali A, Zeng X. Nutraceutical tablets: Manufacturing processes, quality assurance, and effects on human health. Food Res Int. 2024;115197.
Mendonça TF, Barros EG, Pereira GR, Araújo MB, Bonfilio R. Development and validation of a dissolution test for diltiazem hydrochloride in immediate release capsules. Quím Nova. 2011;34(3):520–6. DOI: 10.1590/ S0100-40422011000300027
Novaes CG, Yamaki RT, De Paula VF, Do Nascimento Júnior BB, Barreto JA, Valasques GS, Bezerra MA. Otimização de métodos analíticos usando metodologia de superfícies de resposta-Parte I: variáveis de processo. Rev Virtual Quim. 2017;9(3):1284-1215.
Prasad MB, Vidyadhara S, Sasidhar RLC, Balakrishna T, Trilochani P. Development and evaluation of diltiazem hydrochloride controlled-release pellets by fluid bed coating process. J Adv Pharm Technol Res. 2013;4(2):101–107. DOI: 10.4103/2231-4040.111526.
Rosa TA. Desenvolvimento farmacotécnico e estudos de dissolução de diferentes comprimidos de liberação prolongada de benzonidazol para o tratamento da Doença de Chagas [Dissertation]. Pernambuco: Centro de Ciências da Saúde, Universidade Federal De Pernambuco, 2015. 90p. Available from: https:// repositorio.ufpe.br/handle/123456789/15376.
Sheskey PJ, Cook WG, Cable CG, organizators. Handbook of Pharmaceutical Excipients. 8th ed. London: Pharmaceutical Press; 2017. 1216 p.
Souza MAC, Pereira CEO, Nogueira FHA, Pianetti, GA. In Vitro Dissolution Profiles of Two Diltiazem Tablet Formulations and a Compounded Capsule Formulation: a comparative study. Dissolution Technol. 2017;24(2):38-42. DOI: http://dx.doi.org/10.14227/ dt240217p38.
Usman S, Akram M, Usman A, Fatima S, Islam Q. Development and assessment of immediate-release tablets containing clopidogrel bisulphate & aspirin-strategy for optimizing the combination formulation. PLoS One. 2024;19(5):e0303705. DOI: 10.1371/ journal.pone.0303705.
USP. Monograph: Diltiazem Hydrochloride Tablets, United States Pharmacopeia 43; The United States Pharmacopeial Convention, Inc.: Rockville, MD., 2020.
Van Der Merwe J, Steenekamp J, Steyn D, Hamman J. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics. 2020;12(5):393. DOI: 10.3390/pharmaceutics12050393.
Downloads
Published
Data Availability Statement
Data available from the corresponding author upon reasonable request.
Issue
Section
License
Copyright (c) 2026 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
